K
Kuldeep Singh Sachdeva
Researcher at Government of India
Publications - 82
Citations - 1983
Kuldeep Singh Sachdeva is an academic researcher from Government of India. The author has contributed to research in topics: Tuberculosis & Population. The author has an hindex of 23, co-authored 73 publications receiving 1529 citations. Previous affiliations of Kuldeep Singh Sachdeva include Ministry of Health and Family Welfare.
Papers
More filters
Journal ArticleDOI
Building a tuberculosis-free world: The Lancet Commission on tuberculosis
Michael J. A. Reid,Nimalan Arinaminpathy,Amy Bloom,Barry R. Bloom,Catharina Boehme,Richard E. Chaisson,Daniel P. Chin,Gavin J. Churchyard,Helen Cox,Lucica Ditiu,Mark Dybul,Jeremy Farrar,Anthony S. Fauci,Endalkachew Fekadu,Paula I Fujiwara,Timothy B. Hallett,Christy L Hanson,Mark Harrington,Nick Herbert,Philip C. Hopewell,Chieko Ikeda,Dean T. Jamison,Aamir J. Khan,Irene Koek,Nalini Krishnan,Aaron Motsoaledi,Madhukar Pai,Mario C. Raviglione,Mario C. Raviglione,Almaz Sharman,Small Pm,Soumya Swaminathan,Zelalem Temesgen,Anna Vassall,Anna Vassall,Nandita. Venkatesan,Kitty van Weezenbeek,Gavin Yamey,Bruce D. Agins,Sofia Alexandru,Jason R. Andrews,Naomi Beyeler,Stela Bivol,Grania Brigden,Adithya Cattamanchi,Danielle Cazabon,Valeriu Crudu,Amrita Daftary,Puneet Dewan,Laurie K Doepel,Robert W Eisinger,Victoria Y. Fan,Victoria Y. Fan,Sara Fewer,Jennifer Furin,Jeremy D. Goldhaber-Fiebert,Gabriela B. Gomez,Stephen M. Graham,Stephen M. Graham,Stephen M. Graham,Devesh Gupta,Maureen Kamene,Sunil D. Khaparde,Eunice W Mailu,Enos Masini,Lorrie McHugh,Ellen M. H. Mitchell,Suerie Moon,Suerie Moon,Michael Osberg,Tripti Pande,Lea Prince,Kirankumar Rade,Raghuram Rao,Michelle Remme,James A Seddon,James A Seddon,Casey Selwyn,Priya B. Shete,Kuldeep Singh Sachdeva,Guy Stallworthy,Juan F. Vesga,Valentina Vilc,Eric Goosby +83 more
TL;DR: The Commission recommends five priority investments to achieve a tuberculosis-free world within a generation, which answer the question of how countries with high-burden tuberculosis and their development partners should target their future investments.
Journal ArticleDOI
Index-TB guidelines: Guidelines on extrapulmonary tuberculosis for India.
Surendra K. Sharma,Hannah Ryan,Sunil D. Khaparde,Kuldeep Singh Sachdeva,Achintya D. Singh,Alladi Mohan,Rohit Sarin,C. N. Paramasivan,P. Kumar,Neeraj Nischal,Saurav Khatiwada,Paul Garner,Prathap Tharyan +12 more
TL;DR: The guidelines provide recommendations on three priority areas for EPTB: use of Xpert MTB/RIF in diagnosis, use of adjunct corticosteroids in treatment, and duration of treatment, which are complementary to the existing country standards of TB care and technical operational guidelines for pulmonary TB.
Journal ArticleDOI
How did the TB patients reach DOTS services in Delhi? A study of patient treatment seeking behavior.
TL;DR: The pathways followed by TB patients provide valuable lessons on the importance of different types of providers (both formal and informal) in the health system in a society like India and the delays in the diagnosis and treatment of tuberculosis.
Journal Article
New Vision for Revised National Tuberculosis Control Programme (RNTCP): Universal access - "Reaching the un-reached"
TL;DR: The new vision of RNTCP during the 12th Five Year Plan (2012-2017) aims to achieve ‘Universal access’ to quality assured TB diagnosis and treatment and elaborate plans are being made.
Journal ArticleDOI
Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India
Kuldeep Singh Sachdeva,Neeraj Raizada,Achuthan Sreenivas,Anna H. van’t Hoog,Susan van den Hof,Puneet Dewan,Rahul Thakur,Radhey Shyam Gupta,Shubhangi Kulsange,Bhavin Vadera,Ameet Babre,Christen Gray,Malik Parmar,Mayank Ghedia,Ranjani Ramachandran,Umesh Alavadi,Nimalan Arinaminpathy,Claudia M. Denkinger,Catharina Boehme,C. N. Paramasivan +19 more
TL;DR: The implementation of Xpert MTB/RIF as initial diagnostic test for TB in public health facilities significantly increased case-notification rates of all bacteriologically confirmed TB by 39% and rifampicin-resistant TB case notification by fivefold.